DHR

SELL

Danaher Corporation

Healthcare · Rank #260 · Analyzed Oct 18, 2026

$229.04

Current Price

$161.53

Intrinsic Value

-29.5%

Upside/Downside

2.5/10

Score

2.5/5

Quality

Analysis Summary

Valuation Consensus0/2 methods agree

Quality Score2.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 29.5%

Fair Value Range

Low$74.66

Base (IV)$161.53

High$231.71

Entry Points

Conservative$52.26

Moderate$74.66

Aggressive$113.07

Quality & Moat Breakdown

Return on Equity7.6% → 0/1.0

Debt LevelD/E 53 → 0.5/1.0

Revenue QualityGrowth 3.9%, margin Δ-2.3% +recovery → 1.0/1.0

Moat Strength1.5/5 → 0/1.0

Profit Margins15.9% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.